Recent Updates
Recently added Catalysts
SMTI Positive Sentiment

Q&A Session on Incorporating Hydrolyzed Collagen Surgical Powder into Clinical Practice

Friday, February 13, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses an upcoming Q&A session featuring experts Prodromos Ververeli, MD, Merritt Kinon, MD, and Vivek Mohan, MD, focused on the incorporation of hydrolyzed collagen surgical powder into clinical practice. This session is intended to provide insights and enhance understanding of the product's application in surgery. Attendees are encouraged to seek professional medical advice regarding the use of such products.
Price reaction · baseline $19.425 (2026-02-12 close) · hit pre-market · 1 other SMTI headline(s) in the window, move may be shared
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • The session aims to enhance clinical practice with new insights.
  • Expert presenters bring valuable experience in the field.
  • Focus on hydrolyzed collagen could improve surgical outcomes.

Full Press Release Details

• Last Updated on March 3, 2026
Presenter: Prodromos Ververeli, MD Merritt Kinon, MD Vivek Mohan, MD
Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute for manufacturer instructions nor create new product claims. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Please refer to our Terms of Use .

Related Posts

• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• About Sanara
• Board of Directors
• Surgical Products
• Code of Conduct
• Stock Quote
• Press Releases
• SEC Filings
© 2026 All Rights Reserved. Sanara MedTech Inc.

Frequently Asked Questions

Who are the presenters for the Q&A session?

The presenters are Prodromos Ververeli, MD, Merritt Kinon, MD, and Vivek Mohan, MD.

What is the focus of the Q&A session?

The session focuses on incorporating hydrolyzed collagen surgical powder into clinical practice.

Is the content of the session a substitute for medical advice?

No, the content is for informational purposes only and not a substitute for professional medical advice.

When was the article last updated?

The article was last updated on March 3, 2026.

ShareAdd on Google
Tags: SMTI Viatris Investor Conferences Healthcare Sanara MedTech surgical products clinical practice hydrolyzed collagen medical advice
Last updated: Feb 13, 2026

Biotech snapshot

Cash runway
$29M liquidity · $0M/mo burn
Low dilution risk